Analysis of the Efficacy of Immunotherapy in Elderly Patients with Lung Cancer

Conclusion The efficacy and safety of immunotherapy in elderly patients were similar to those in younger patients, and PFS was superior in the first-line immunotherapy. Further prospective studies are still needed to explore predictors of immunotherapy in elderly NSCLC patients. 
 DOI: 10.3779/j.issn.1009-3419.2022.102.16
Source: Chinese Journal of Lung Cancer - Category: Cancer & Oncology Source Type: research